The architecture and biological performance of drug-loaded LbL nanoparticles
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Layer-by-Layer (LbL) nanoparticles are an emerging class of therapeutic carriers that afford precise control over key design parameters that facilitate improved drug and carrier pharmacokinetics, and enhanced molecular-targeting capabilities. This paper advances the development of these systems by establishing them as drug carriers, with the means to control drug release in a systemic environment and retard particle clearance from circulation, promoting improved biodistribution of the drug-containing system. Using dual-fluorescent tracking in vivo, this work establishes a robust means of screening libraries of LbL systems generated, affording simultaneous resolution over persistence and biodistribution of both the drug and carrier following systemic administration of a single particle formulation. Employing a PLGA drug-containing core as a substrate for LbL deposition, a range of coated systems were fabricated to investigate the abilities of these films to stabilize drug for delivery as well as to improve the pharmacokinetics of both the drug and carrier. Significant reductions in liver accumulation were observed for different formulations of the layered architectures within the first 30 minutes of systemic circulation. LbL architectures diminished liver localization of the surrogate drug, cardiogreen, by 10–25% ID/g relative to native PLGA nanoparticles and modulated carrier accumulation in the liver >50% ID/g. Further, enhanced persistence of the drug was observed with the coated systems, significantly increasing the drug half-life from 2–3 minutes for free drug and 1.87h for the uncoated core to 4.17h and 4.54h for the coated systems. These systems provide an exciting, modular platform that improves the pharmacokinetic properties of the therapeutic, reduces bolus release of drug from nanoparticles, and enhances the safety and circulation half-life of the drug in vivo, proving them to be highly clinically-relevant and a promising approach for future development of molecularly-targeted and combination therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533 · cited 1×
“hydrated coatings to minimize protein adsorption and opsonization[36–39]; as such, they present promising biodegradable, biomimetic alternatives to the traditional and widelyreported use of poly(ethylene glycol).[40] Further, HA is a known ligand for CD44 receptors[41], which are characteristically overexpressed in ma…”
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376 · cited 1×
“LbL architectures that act as highly effective stabilizing layers were demonstrated to impart long circulation times andEPR-based (Enhanced Permeability andRetention) passive targeting to the resulting systems [29].”
Faisant, N., Siepmann, J., & Benoit, J. P. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00023-4 · Cited by 346
Layer-by-Layer Nanoparticles with a pH-Sheddable Layer for in Vivo Targeting of Tumor Hypoxia
Poon, Z., Chang, D., Zhao, X., & Hammond, P. T. (2011) · ACS Nano · doi:10.1021/nn200876f · Cited by 343
Self-citation
Cited by
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Deng, Z. J., Morton, S. W., Ben-Akiva, E., Dreaden, E. C., Shopsowitz, K. E., & Hammond, P. T. (2013) · ACS Nano · doi:10.1021/nn4047925 · Cited by 516
Self-citationImpact of particle elasticity on particle-based drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.007 · Cited by 385
Sustained-release from nanocarriers: a review
Natarajan, J. V., Nugraha, C., Ng, X. W., & Venkatraman, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.029 · Cited by 285
Cheng, G., Yin, C., Tu, H., Jiang, S., Wang, Q., Zhou, X., Xing, X., Xie, C., Shi, X., Du, Y., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b06032 · Cited by 255
Metadata
- Authors
- Morton, S. W., Poon, Z., & Hammond, P. T.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 34
- Issue
- 21
- Pages
- 5328-5335
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2056709531
- Cited by
- 107
- References
- 4
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The architecture and biological performance of drug-loaded LbL nanoparticles. https://app.cochat.ai/papers/10.1016/j.biomaterials.2013.03.059
- The paper
- Morton, S. W., Poon, Z., & Hammond, P. T. (2013). The architecture and biological performance of drug-loaded LbL nanoparticles. Biomaterials. https://doi.org/10.1016/j.biomaterials.2013.03.059
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.